Detail
Článek
Článek online
FT
Medvik - BMČ
  • Je něco špatně v tomto záznamu ?

The effect of combined diet containing n-3 polyunsaturated fatty acids and silymarin on metabolic syndrome in rats

M. Poruba, P. Anzenbacher, Z. Racova, O. Oliyarnyk, M. Hüttl, H. Malinska, I. Markova, S. Gurska, L. Kazdova, R. Vecera

. 2019 ; 68 (Suppl 1) : S39-S50. [pub] 20191122

Jazyk angličtina Země Česko

Typ dokumentu časopisecké články

Perzistentní odkaz   https://www.medvik.cz/link/bmc21028164

The risk of development of metabolic syndrome can be increased by hypertriglyceridemia. A search for effective therapy is a subject of considerable attention. Therefore, our hypothesis is that the fish oil (containing polyunsaturated fatty acids; n-3 PUFA) in a combination with silymarin can more effectively protect against hypertriglyceridemia-induced metabolic disturbances. The study was conducted using a unique non-obese strain of rats with hereditary hypertriglyceridemia an accepted model of metabolic syndrome. Adult male rats were treated with n-3 PUFA (300 mg/kg/day) without or with 1 % micronized silymarin in a diet for 4 weeks. The treatment with the diet containing n-3 PUFA and silymarin significantly reduced concentrations of serum triglycerides (-45 %), total cholesterol (-18 %), non-esterified fatty acids (-33 %), and ectopic lipid accumulation in skeletal muscle (-35 %) compared to controls. In addition, an increase in Abcg5 and Abcg8 mRNA expression (as genes affecting lipid homeostasis) as well as in protein content of ABCG5 (+78 %) and ABCG8 (+232 %) transporters have been determined in the liver of treated rats. Our findings suggest that this combined diet could be used in the prevention of hypertriglyceridemia-induced metabolic disorders.

Citace poskytuje Crossref.org

Bibliografie atd.

Literatura

000      
00000naa a2200000 a 4500
001      
bmc21028164
003      
CZ-PrNML
005      
20220328134205.0
007      
ta
008      
211105s2019 xr d f 000 0|eng||
009      
AR
024    7_
$a 10.33549/physiolres.934322 $2 doi
035    __
$a (PubMed)31755289
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a xr
100    1_
$a Poruba, Martin $7 xx0230224 $u Department of Pharmacology, Faculty of Medicine and Dentistry, Palacky University Olomouc, Olomouc, Czech Republic
245    14
$a The effect of combined diet containing n-3 polyunsaturated fatty acids and silymarin on metabolic syndrome in rats / $c M. Poruba, P. Anzenbacher, Z. Racova, O. Oliyarnyk, M. Hüttl, H. Malinska, I. Markova, S. Gurska, L. Kazdova, R. Vecera
504    __
$a Literatura
520    9_
$a The risk of development of metabolic syndrome can be increased by hypertriglyceridemia. A search for effective therapy is a subject of considerable attention. Therefore, our hypothesis is that the fish oil (containing polyunsaturated fatty acids; n-3 PUFA) in a combination with silymarin can more effectively protect against hypertriglyceridemia-induced metabolic disturbances. The study was conducted using a unique non-obese strain of rats with hereditary hypertriglyceridemia an accepted model of metabolic syndrome. Adult male rats were treated with n-3 PUFA (300 mg/kg/day) without or with 1 % micronized silymarin in a diet for 4 weeks. The treatment with the diet containing n-3 PUFA and silymarin significantly reduced concentrations of serum triglycerides (-45 %), total cholesterol (-18 %), non-esterified fatty acids (-33 %), and ectopic lipid accumulation in skeletal muscle (-35 %) compared to controls. In addition, an increase in Abcg5 and Abcg8 mRNA expression (as genes affecting lipid homeostasis) as well as in protein content of ABCG5 (+78 %) and ABCG8 (+232 %) transporters have been determined in the liver of treated rats. Our findings suggest that this combined diet could be used in the prevention of hypertriglyceridemia-induced metabolic disorders.
650    _2
$a zvířata $7 D000818
650    _2
$a antioxidancia $x metabolismus $7 D000975
650    12
$a dieta $7 D004032
650    _2
$a modely nemocí na zvířatech $7 D004195
650    _2
$a dyslipidemie $x terapie $7 D050171
650    _2
$a omega-3 mastné kyseliny $x aplikace a dávkování $7 D015525
650    _2
$a rybí oleje $7 D005395
650    _2
$a exprese genu $x účinky léků $7 D015870
650    _2
$a hypertriglyceridemie $x komplikace $x farmakoterapie $x genetika $7 D015228
650    _2
$a metabolismus lipidů $x účinky léků $x genetika $7 D050356
650    _2
$a peroxidace lipidů $x účinky léků $7 D015227
650    _2
$a lipidy $x krev $7 D008055
650    _2
$a mužské pohlaví $7 D008297
650    _2
$a metabolický syndrom $x etiologie $x prevence a kontrola $7 D024821
650    _2
$a oxidační stres $x účinky léků $7 D018384
650    _2
$a krysa rodu Rattus $7 D051381
650    _2
$a potkani Wistar $7 D017208
650    _2
$a silymarin $x aplikace a dávkování $7 D012838
655    _2
$a časopisecké články $7 D016428
700    1_
$a Anzenbacher, Pavel, $d 1947- $7 xx0034447 $u Department of Pharmacology, Faculty of Medicine and Dentistry, Palacky University Olomouc, Olomouc, Czech Republic
700    1_
$a Rácová, Zuzana $7 xx0109661 $u Department of Pharmacology, Faculty of Medicine and Dentistry, Palacky University Olomouc, Olomouc, Czech Republic
700    1_
$a Oliyarnyk, Olena $7 xx0095365 $u Center of Experimental Medicine, Institute for Clinical and Experimental Medicine, Prague, Czech Republic
700    1_
$a Hüttl, Martina $7 xx0230591 $u Center of Experimental Medicine, Institute for Clinical and Experimental Medicine, Prague, Czech Republic
700    1_
$a Malínská, Hana $7 xx0158953 $u Center of Experimental Medicine, Institute for Clinical and Experimental Medicine, Prague, Czech Republic
700    1_
$a Marková, Irena $7 xx0161888 $u Center of Experimental Medicine, Institute for Clinical and Experimental Medicine, Prague, Czech Republic
700    1_
$a Gurská, Soňa $7 xx0267298 $u Institute of Molecular and Translational Medicine, Faculty of Medicine and Dentistry, Palacky University Olomouc, Olomouc, Czech Republic
700    1_
$a Kazdová, Ludmila, $d 1938- $7 xx0053119 $u Center of Experimental Medicine, Institute for Clinical and Experimental Medicine, Prague, Czech Republic
700    1_
$a Večeřa, Rostislav, $d 1965- $7 mzk2004236742 $u Department of Pharmacology, Faculty of Medicine and Dentistry, Palacky University Olomouc, Olomouc, Czech Republic
773    0_
$w MED00003824 $t Physiological research $x 1802-9973 $g Roč. 68, Suppl 1 (2019), s. S39-S50
773    0_
$t 69th Czech-Slovak pharmacological days $g (2019), s. S39-S50 $w MED00208902
856    41
$u https://pubmed.ncbi.nlm.nih.gov/31755289 $y Pubmed
910    __
$a ABA008 $b A 4120 $c 266 $y p $z 0
990    __
$a 20211105 $b ABA008
991    __
$a 20220328134203 $b ABA008
999    __
$a ok $b bmc $g 1728767 $s 1148709
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2019 $b 68 $c Suppl 1 $d S39-S50 $e 20191122 $i 1802-9973 $m Physiological research $n Physiol. Res. (Print) $x MED00003824
BMC    __
$a 2019 $d S39-S50 $m 69th Czech-Slovak pharmacological days $x MED00208902
LZP    __
$b NLK118 $a Pubmed-20211105

Najít záznam

Citační ukazatele

Nahrávání dat ...

Možnosti archivace

Nahrávání dat ...